Blood and swab tests could predict preterm birth risk
NCT ID NCT04067908
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study investigates whether new biomarkers found in blood and vaginal samples can help predict the risk of premature delivery in pregnant women showing signs of preterm labor. Researchers will collect extra blood and swab samples from women between 22 and 33 weeks of pregnancy who are experiencing contractions or cervical changes. The goal is to see if these markers can identify who will deliver before 37 weeks, especially before 34 weeks, to improve early detection and care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple test that helps doctors predict which women are at risk of premature delivery, allowing earlier interventions.
- What could go wrong
- This is an observational study, not a treatment trial. The biomarkers may not prove accurate enough for clinical use, and results may not apply to all pregnancies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREMATURE DELIVERY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.